Status:
RECRUITING
CT-guided Lung Biopsy Risk Optimization Method
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Pneumothorax
Biopsy, Needle
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of this randomized controlled study is to evaluate the extent to which injection of a small amount of fluid in the pleural cavity at the biopsy site may reduce the risk of pneumothoraces, ...
Detailed Description
Study participants with written consent and the percutaneous, CT-guided lung biopsy already regularly indicated by the referring doctors (e.g., oncology) will be part of this study and will be randomi...
Eligibility Criteria
Inclusion Criteria:
- Ability to provide informed consent (knowledge of project languages), >18 years.
- Indeterminate or suspicious lung lesion unsuitable for transbronchial biopsy or Status after unsuccessful transbronchial biopsy
- Indication for biopsy given by referring specialist (in patients).
Exclusion Criteria:
- Preintervention bleeding into the pleural cavity
- More than 1 lesion should be biopsied at the same time
- Infiltration of the thoracic wall
- Pregnancy
Key Trial Info
Start Date :
September 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT06340178
Start Date
September 29 2025
End Date
April 1 2027
Last Update
February 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 10
Bern, Switzerland, 3010